When some individuals spend just a few hours at low atmospheric pressure above 1,500 m (5,000 ft) - such as when climbing a mountain or flying in a plane at high altitude - they become ill. Altitude sickness studies originally concentrated on life-threatening illnesses which beset determined and athletic climbers at extreme altitudes. In recent years, however, research attention is moving towards milder forms of sickness reported by a significant proportion of the growing number of visitors to mountain and ski resorts at more moderate altitude. Some of this research is also relevant in understanding the problems experienced by passengers in newer planes that fly at a significantly higher equivalent cabin altitude, i.e. 2,440 m (8,000 ft), than earlier designs. Engineering solutions - such as enriched oxygen in enclosed spaces at altitude, or in the case of aircraft, lower cabin altitudes - are possible, but for an economic assessment to be realistic an engineer needs to identify the scale of the problem and to understand the factors determining susceptibility.
This review concentrates on the problems of mountain sickness in the ordinary population at altitudes of around 3,000 m (10,000 ft); this is a problem of growing concern as ski resorts develop, mountain trekking increases in popularity, and as higher altitude cabin pressures are achieved in aircraft.
ANHOLM J D , HOUSTON C S and HYERS T M (1979). The relationship between acute mountain sickness and pulmonary ventilation at 2,835 m (9,300 ft) . Chest; 75(1), 33-36
2.
ANHOLM J D , POWLES A C , DOWNEY R , HOUSTON C S , SUTTON J R and BONNET M H (1992). Operation Everest 11: arterial oxygen saturation and sleep at extreme simulated altitude . Am Rev Resp Dis; 145(Part 4), 817-826
3.
BASNYAT B , LEMASTER J and LITCH J A (1999). Everest or bust: a cross sectional epidemiological study of acute mountain sickness at 4,243 meters in the Himalayas . Aviat Space Environ Med; 70(9), 867-873
4.
BEHAN R (2001). Inquiry launched into cabin air quality . Daily Telegraph, Travel Section, p. 4 , 17 February
5.
BENDZ B , ROSTRUP M , SEVRE K , ANDERSEN T O and SANDSET P M (2000). Association between acute hypobaric hypoxia and activation of coagulation in human beings . Lancet; 356, 1657-1658
6.
BERGHOLD F (2000). Diagnosis and therapy of acute altitude sickness . Wein Med Wochenschr; 150(8-9), 169-174 (in German)
7.
BEZRUCHKA S (1994). Altitude Illness, Prevention and Treatment. Leicester: Cordee
8.
BOTELLA DE MAGLIA J and MARTINEZ-COSTA R (1998). High altitude retinal haemorrhages in the expeditions to 8,000 meter peaks. A study of 10 cases . Med Clin (Barc); 110(12), 457-461 (in Spanish)
9.
BROWN T P , SHUKER L K , RUSHTON L , WARREN F and STEVENS J (2001). The possible effects on health, comfort and safety of aircraft cabin environments . J Roy Soc Health; 121(3), 177-184
10.
BRUNDRETT G W (2001). Comfort and health in commercial aircraft: a literature review . J Roy Soc Health; 121(1), 29-37
11.
BUTLER F K , HARRIS D J and REYNOLDS R D (1992). Altitude retinopathy on Mount Everest, 1989 . Ophthalmol; 99, 739-746 (cited in Heath and Williams, 1995)
12.
CLARKE C (1999). UIAA Mountain Medicine Centre Information Sheet 1. Mountain Sickness, Oedema and Travel to High Altitudes. International Union of Alpine Associations (UIAA) Mountain Medicine Centre . Available online at: www.thebmc.co.uk/mm/mm1.html (accessed 21 February 2002)
13.
CLARKE C and DUFF J (1976). Mountain sickness, retinal haemorrhages and acclimatisation on Mount Everest in 1975 . BMJ; 2, 495-497 (cited in Heath and Williams, 1995)
COTTRELL J J , LEBORITZ B L , FENNEL R G and KOHN G M (1995). In flight arterial saturation; continuous monitoring by pulse oximetry . Aviat Space Environ Med; 66(2), 126-130
16.
CURTIS R (1995) Outdoor Action Guide to High Altitude: Acclimatization and Illnesses. Outdoor Action Program, Princeton University
17.
DIETZ T E (2001). All About Altitude Illness. Emergency and Wilderness Medicine. Available online at: www.high-altitude-medicine.com/AMS.html (accessed 21 February 2002)
18.
DONALDSON E and PEARN J (1996). First aid in the air . Aust N Z J Surg; 66(7), 431-434
19.
DUMONT L , MARDIROSOFF C and TRAMER M R (2000). Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systems review . BMJ; 321, 267-272
20.
EICHENBERGER U , WEISS E , RIEMANN D , OELZ O and BARTSCH P (1996). Nocturnal periodic breathing and the development of acute high altitude illness . Am J Respir Crit Care Med; 154 (6 part 1), 1748-1754
21.
ERNSTING J (1978). Prevention of hypoxia-acceptable compromises . Aviat Space Environ Med; 49(3), 495-502
22.
FRAYSER R , HOUSTON C S , BRYAN A C , RENNIE I D and GRAY G (1970). Retinal haemorrhage at high altitude . N Engl J Med; 282(21), 1183-1184
23.
GILBERT D L (1983). The first documented report of mountain sickness: the China or Headache Mountain story . Resp Physiol; 52, 315-326
24.
HACKETT P H and OELZ O (1992). The Lake Louise Consensus on the Definition and Quantification of Altitude Sickness. In: Hypoxia and Mountain Sickness, pp. 327-330. (Edited by Sutton J R , Coates G and Houston C S. ) Burlington, Vermont: Queen City Printers
25.
HACKETT P H and RENNIE D (1976). The incidence, importance and prophylaxis of acute mountain sickness . Lancet; 2, 1149-1155
26.
HACKETT P H and RENNIE D (1979). Rales, peripheral edema, retinal hemorrhage and acute mountain sickness . Am J Med; 67(2), 214-218
27.
HACKETT P H , RENNIE D , HOFMEISTER S E , GROVER E B and REEVES J T (1982). Fluid retention and relative hypoventilation in acute mountain sickness . Respir; 43(5), 321-329
28.
HARDING R M and GRADWELL D P (1999). Hypoxia and Hyperventilation. In: Aviation Medicine, pp. 43-58. Third Edition. (Edited by Ernsting J , Nicholson A N and Rainford D J. ) Oxford: Butterworth-Heinemann
29.
HARDING R M and MILLS F J (EDITORS) (1993). Aviation Medicine. London: BMJ Publishing Group
30.
HEATH D and WILLIAMS D R (1995). High Altitude Medicine and Pathology. Oxford: Oxford University Press
31.
HOHENHAUS E , PAUL A , MCCULLOUGH R E , KUCHERER H and BARTSCH P (1995). Ventilatory and pulmonary vascular response to hypoxia and susceptibility to high altitude pulmonary oedema . Eur Respir J; 8(11), 1825-1833
32.
HONIGMAN B , THEIS M K , KOZIOLMCLAIN J , ROACH R , YIP R , HOUSTON C , et al (1993). Acute mountain sickness in a general tourist population at moderate altitudes . Ann Intern Med; 118(8), 587-592
33.
HOUSTON C S (1985). Incidence of acute mountain sickness . Am Alpine J; 27, 162-165
34.
ICAO (INTERNATIONAL CIVIL AVIATION ORGANISATION) (1964). Manual of the ICAO Standard Atmosphere. International Civil Aviation Organisation, Quebec, Canada
35.
JOHNSON T S and ROCK P B (1988). Current concepts: acute mountain sickness . N Engl J Med; 319(13), 841-845
36.
KELLER H R , MAGGIORINI M , BARTSCH P and OELZ O (1995). Simulated descent v dexamethasone in treatment of acute mountain sickness. A randomised trial . BMJ; 310, 1232-1235
37.
LAMBERT A (1993). The Central of Peru. The Highest Railway in the World, pp. 132-137. In: Train Journeys of the World. (Edited by Gordon S. ) Basingstoke: Automobile Association
38.
LARKIN M (1999). Braving the peaks? Be prepared . Lancet; 354, 782
39.
LITCH J A and BISHOP R A (2000). High altitude global amnesia . Wilderness Environ Med; 11(1), 25-28
40.
LUKS A M , VAN MELICK H , BATARSE R R , POWELL F L , GRANT I and WEST J B (1998). Room oxygen enrichment improves sleep and subsequent day-time performance at high altitude . Respir Physiol; 113(3), 247-258
41.
MAGGIORINI M , MULLER A , HOFSTETTER D , BARTSCH P and OELZ O (1998). Assessment of acute mountain sickness by different score protocols in the Swiss Alps . Aviat Space Environ Med; 69(12), 1186-1192
42.
MCFADDEN D M , HOUSTON C S , SUTTON J R , POWLES A C , GRAY G W and ROBERTS R S (1981). High-altitude retinopathy . J Am Med Assoc; 245, 581-586
43.
MCFARLAND R A (1953). Human Factors in Air Transportation. New York: McGraw-Hill Book Co
44.
MENON N D (1965). High altitude pulmonary oedema . N Engl J Med; 273, 66-74
45.
MONTGOMERY A B , MILLS J and LUCE J M (1989). Incidence of acute mountain sickness at intermediate altitude . JAMA; 261(5), 732-734
46.
MUKHOPADHYAY S , THAKUR L , ANAND J P and SELVAMURTHY W (2000). Effects of sojourn at altitude of 3,500 m on auditory evoked potential in man . Indian J Physiol Pharmacol; 44(2), 211-214
47.
MURDOCH D R and CURRY C (1998). Acute mountain sickness in the Southern Alps of New Zealand . N Z Med J; 111(1065), 168-169
48.
NICHOLAS M , THULLIER-LESTIENNE F , BOUQUET C , GARDETTE B , GORTAN C , RICHALET J P , et al (2000). A study of mood changes and personality during a 31 day period of chronic hypoxia in a hypobaric chamber (Everest-Comex 97) . Psychol Rep; 86(1), 119-126
49.
NICHOLSON A N , SMITH P A , STONE B M , BRADWELL A R and COOTE J H (1988). Altitude insomnia: studies during an expedition to the Himalayas . Sleep; 11(4), 354-361
50.
RENNIE D and MORRISSEY J (1975). Retinal changes in Himalayan climbers . Arch Ophthalmol; 93, 395-400 (cited in Heath and Williams, 1995)
51.
ROACH R C , GREENE E R , SCHOENE R B and HACKETT P H (1998). Arterial oxygen saturation for prediction of acute mountain sickness . Aviat Space Environ Med; 69(12), 1182-1185
52.
ROACH R C , LARSON E B , HORNBEIN T F , HOUSTON C S , BARTLETT S , HARDESTY J , et al (1983). Acute mountain sickness, antacids and ventilation during rapid, active ascent of Mount Rainier . Aviat Space Environ Med; 54(5), 397-401
53.
ROACH R C , MAES D , SANDOVAL D , ROBERGS R A , ICENOGLE M , HINGHOFER-SZALKAY H , et al (2000). Exercise exacerbates acute mountain sickness at simulated altitude . J Appl Physiol; 88(2), 581-585
54.
ROGGLA G , MOSER B , WAGNER A and ROGGLA M (2000a). Correlation between raised body temperature and acute mountain sickness score at moderate altitude . Wien Klin Wochenschr; 112(6), 290-292 (in German)
55.
ROGGLA G , MOSER B , DOMEJ W and ROGGLA M (2000b). Physical exercise impairs the acute stage of adaptation to moderate altitude . Wien Med Wochenschr; 150(8-9), 195-196 (in German)
56.
RYAN E T and KAIN K C (2000). Health advice and immunizations for travellers . N Engl J Med; 342(23), 1716-1725
57.
SAITO S , NISHIHARA F , TAKAZAWA T , KANAI M , ASO C , SHIGA T , et al (1999). Exercise-induced cerebral deoxygenation among untrained trekkers at moderate altitudes . Arch Environ Health; 54(940), 271-276
58.
SAITO S , ASO C , KANAI M , TAKAZAWA T , SHIGA T and SHIMADA H (2000). Experimental use of a transportable hyperbaric chamber durable for 15 psi at 3,700 meters above sea level . Wilderness Environ Med; 11(1), 21-24
59.
SCHIMMELPFENIG T and LINDSEY L (1991). Altitude Illness. In: National Outdoor Leadership School (NOLS) Wilderness First Aid Handbook. Wyoming: NOLS . Available online at: www.nols.edu
60.
SCHUMACHER G A and PETAJAN J H (1975). High altitude stress and retinal haemorrhage: relation to vascular headache mechanisms . Arch Environ Health; 30, 217-221 (cited in Heath and Williams, 1995)
61.
SHULTS W T and SWAN K C (1975). High altitude retinography in mountain climbers . Arch Ophthalmol; 93, 404-409
62.
SINGH S B , CHATTERJEE A , PANJWANI U , YADAV D K , SALVAMURTHY W and SHARMA K N (2000). Effect of high altitude on sensitivity to the taste of phenylthiocarbamide . Int J Biometeorol; 44(1), 20-23
63.
TAIT P (1999). Safety in Civil Operations. In: Aviation Medicine. Third edition. (Edited by Ernsting J , Nicholson A N and Rainford D J. ) Oxford: Butterworth Heinemann
64.
WEST J B (1998). High Life. A History of High Altitude Physiology and Medicine. Oxford: Oxford University Press
65.
WEST J B (1999). Oxygen enrichment of room air to improve well-being and productivity at high altitude . Int J Occup Environ Health; 5(3), 187-193
66.
YARON M , WALDMAN N , NIERMEYER S , NICHOLAS R and HONIGMAN B (1998). The diagnosis of acute mountain sickness in preverbal children . Arch Pediatr Adolesc Med; 152(7), 683-687
67.
ZAFREN K and HONIGMAN B (1997). High altitude medicine . Emerg Med Clin N Am; 15(1), 191-222
